A phase II study of bortezomib in patients with MALT lymphoma

We have performed a phase II study to evaluate bortezomib in patients with MALT-lymphoma. Sixteen patients entered the trial, 4 had gastric MALT-lymphoma, 7 of the ocular adnexa, one of the colon, and 2 of the parotid, and one patient each the lung and the breast. Bortezomib was given at 1.5 mg/m(2)...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Troch, Marlene, Jonak, Constanze, Müllauer, Leonhard, Püspök, Andreas, Formanek, Michael, Hauff, Wolfgang, Zielinski, Christoph C., Chott, Andreas, Raderer, Markus
Natura: Artigo
Lingua:Inglês
Pubblicazione: Ferrata Storti Foundation 2009
Soggetti:
Brief Reports
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2675689/
https://ncbi.nlm.nih.gov/pubmed/19336742
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2008.001537
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi